SUBSCRIBE
SUBSCRIBE

Chiesi, USA

NEWS
Business
Santhera Announces Closing of Licensing Transaction with Chiesi Group for Raxone® in LHON
Pratteln, Switzerland, August 2, 2019 – Santhera Pharmaceuticals announces the closing of the licensing transaction with Chiesi Farmaceutici, an international research-focused healthcare group.
August 4, 2019
 · 
4 min read
Load More
JOBS
IN THE PRESS
Deals
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
March 22, 2023
 · 
6 min read
Business
Chiesi appoints Giuseppe Accogli as new Group CEO
January 30, 2023
 · 
2 min read
Deals
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
January 8, 2023
 · 
12 min read
Bio NC
Chiesi USA Sponsors ASHP Advantage Initiative to Support Pharmacy Technician Recruitment and Retention
December 2, 2022
 · 
6 min read
Bio NC
Chiesi USA Announces Publication of Health Economics Analysis of Selective Early Rescue Surfactant Administration vs. Standard Surfactant Administration for Premature Infants with Respiratory Distress Syndrome
November 29, 2022
 · 
5 min read
Bio NC
Chiesi USA Chosen as One of Fortune’s 25 Best Small and Medium Workplaces in Biotechnology and Pharmaceuticals
October 17, 2022
 · 
4 min read
Bio NC
Chiesi tracks actions taken for a healthier, more sustainable future
July 14, 2022
 · 
8 min read
Bio NC
Chiesi USA certified as a Great Place to Work® in 2021
February 24, 2022
 · 
5 min read
Bio NC
A new clinical framework redefines the diagnosis of COPD Exacerbations
December 20, 2021
 · 
6 min read
Bio NC
Chiesi accelerates path toward full sustainability despite COVID-19 pandemic
June 23, 2021
 · 
9 min read
Load More